The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular degeneration.

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, has presented new data on its lead ...

Opthea is a clinical-stage biotech firm developing Sozinibercept, targeting VEGF-C and VEGF-D for wet AMD, with Phase 3 results due in 2025. Read more here.

The global ophthalmic diagnostic equipment market is poised for steady growth, with projections estimating a market value of ...

Vegetables are undeniably healthy, packed with vitamins, minerals, fiber, antioxidants, anti-inflammatory compounds, and ...

Do you have blue eyes? We talked to experts to discover curious facts about baby blues, including whether your biological family is bigger than you ever imagined.

Siloton’s handheld OCT system could soon be used for home-based monitoring of retinal disease, and may one day find its way onto future space missions ...

Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal ...

With data from over 37,000 individuals across 50+ conditions, Health Union's 2024 syndicated healthcare research findings provide fresh perspectives on treatment satisfaction, quality of life, and ...

Announced positive interim data for DURAVYU 2.7mg in DME demonstrating meaningful, early and sustained visual acuity gains, strong anatomical ...

Launching in Specsavers stores on November 7, the eyewear line includes Elsaesser's signature pop-art inspired accents and playful ...